Angiotensin II blockers improve cardiac coronary flow under hemodynamic pressure overload

doi:10.1038/s41440-021-00617-1

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 藥學系(所) > 期刊論文 > Item 310902800/34475

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34475

標題:	Angiotensin II blockers improve cardiac coronary flow under hemodynamic pressure overload
作者:	Chang, Wei-Ting Fisch, Sudeshna Dangwal, Seema Chen, Michael Cheng, Susan Chen, Zhih-Cherng Liao, Ronglih
貢獻者:	Natl Cheng Kung Univ, Coll Med, Inst Clin Med Chi Mei Med Ctr, Dept Cardiol Southern Taiwan Univ Sci & Technol, Dept Biotechnol Harvard Med Sch, Dept Med, Brigham & Womens Hosp, Boston Stanford Univ, Stanford Cardiovasc Inst, Dept Med, Sch Med Smidt Heart Inst Cedars Sinai Med Ctr, Barbra Streisand Womens Heart Ctr Chia Nan Univ Pharm & Sci, Dept Pharm
關鍵字:	Coronary flow velocity Hypertension Angiotensin receptor blockers Calcium channel blockers Cardiac fibrosis
日期:	2021
上傳時間:	2023-11-11 11:56:10 (UTC+8)
出版者:	SPRINGERNATURE
摘要:	Coronary flow velocity (CFV) is reduced in pathologic cardiac hypertrophy. This functional reduction is linked to adverse cardiac remodeling, hypertension and fibrosis, and angiotensin II (AngII) is a key molecular player. Angiotensin receptor blockers (ARBs) are known to attenuate adverse cardiac remodeling and fibrosis following increased afterload, while the mechanism by which these drugs offer clinical benefits and regulate hemodynamics remains unknown. To establish a direct connection between coronary flow changes and angiotensin-induced hypertension, we used a Doppler echocardiographic method in two distinct disease models. First, we performed serial echocardiography to visualize coronary flow and assess heart function in patients newly diagnosed with hypertension and currently on ARBs or calcium channel blockers (CCBs). CFV improved significantly in the hypertensive patients after 12 weeks of ARB treatment but not in those treated with CCBs. Second, using murine models of pressure overload, including Ang II infusion and aortic banding, we mimicked the clinical conditions of Ang II- and mechanical stress-induced hypertension, respectively. Both Ang II infusion and aortic banding increased the end-systolic pressure-volume relationship and cardiac fibrosis, but interestingly, only Ang II infusion resulted in a significant reduction in CFV and corresponding activation of pressure-sensitive proteins, including connective tissue growth factor, hypoxia-inducible factor 1 alpha and signal transducer and activator of transcription 3. These data support the existence of a molecular and functional link between AngII-induced hemodynamic remodeling and alterations in coronary vasculature, which, in part, can explain the clinical benefit of ARB treatment in hypertensive patients.
關聯:	HYPERTENS RES, v.44, n.7, pp.803-812
显示于类别:	[藥學系(所)] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	77	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....